Temporal Trends in Hematopoietic Stem Cell Transplantation in Argentina: Regional Differences That Mirror the Global Reality
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Nagler A
. Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis in Alternative Donor Stem Cell Transplantation: Immune Reconstitution and Infection Risk. Transplant Cell Ther. 2021; 27(11):883-884.
DOI: 10.1016/j.jtct.2021.09.023.
View
2.
Basquiera A, Odstrcil Bobillo M, Peroni M, Thomas D, Vitriu A, Berro M
. Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI. Hematol Transfus Cell Ther. 2022; 45(2):224-234.
PMC: 10244243.
DOI: 10.1016/j.htct.2022.02.008.
View
3.
Rocha V, Fatobene G, Niederwieser D
. Increasing access to allogeneic hematopoietic cell transplant: an international perspective. Hematology Am Soc Hematol Educ Program. 2021; 2021(1):264-274.
PMC: 8791161.
DOI: 10.1182/hematology.2021000258.
View
4.
Giebel S, Labopin M, Ibatici A, Browne P, Czerw T, Socie G
. Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT. Oncologist. 2016; 21(3):377-83.
PMC: 4786353.
DOI: 10.1634/theoncologist.2015-0314.
View
5.
Passweg J, Baldomero H, Bader P, Bonini C, Duarte R, Dufour C
. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant. 2017; 52(6):811-817.
PMC: 5467246.
DOI: 10.1038/bmt.2017.34.
View